From: Secondary infection in COVID-19 critically ill patients: a retrospective single-center evaluation
Total study cohort n = 94 | No secondary infection n = 30 | Secondary infection n = 64 | P value |
---|---|---|---|
Baseline characteristics | |||
Age (years) | 71.43 ± 9.65 | 67.92 ± 10.86 | 0.13 |
BMI (kg/m2) | 26.99 ± 6.68 | 28.09 ± 5.63 | 0.99 |
Gender (male) | 13 (43.3%) | 42 (65.6%) | 0.04 |
DNI code | 9 (30.0%) | 6 (9.4%) | 0.01 |
No DNI code | 21 (70%) | 58 (90.6%) | |
Co-morbidities | |||
Smoking | 1 (3.3%) | 3(4.7%) | 0.75 |
Reumatological disease | 4 (13.3%) | 4 (6.3%) | 0.25 |
Obesity | 9 (30.0%) | 22 (34.4%) | 0.67 |
Arterial hypertension | 22 (73.3%) | 36 (56.3%) | 0.11 |
Diabetes mellitus | 14 (46.7%) | 18 (28.1%) | 0.07 |
Severity of illness PaO2/FiO2 at admission Worst PaO2/FiO2 | 126.5 ± 108.5 103.4 ± 90.16 | 149.0 ± 158.6 91.26 ± 60.91 | 0.44 0.73 |
APACHE IV score | 50.1 ± 16.7 | 47.0 ± 15.9 | 0.97 |
SOFA score | 5.2 ± 3.4 | 4.5 ± 3.2 | 0.20 |